TNP-351
CAS No. 125991-51-7
TNP-351( TNP351 )
Catalog No. M11069 CAS No. 125991-51-7
TNP-351 is an antifolate compound that functions as a DHFR inhibitor, strongly inhibits the growth of Meth A cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1053 | Get Quote |
|
| 50MG | 2142 | Get Quote |
|
| 100MG | 2790 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTNP-351
-
NoteResearch use only, not for human use.
-
Brief DescriptionTNP-351 is an antifolate compound that functions as a DHFR inhibitor, strongly inhibits the growth of Meth A cells.
-
DescriptionTNP-351 is an antifolate compound that functions as a DHFR inhibitor, strongly inhibits the growth of Meth A cells.
-
In VitroTNP-351 inhibits the proliferation of mouse L1210 leukemia cells and human CCRF-CEM lymphoblastic leukemia cells with ED50 values of 0.79 and 2.7 nM, respectively. The ED50 values determined for the parent cell line CCRF-CEM, CCRFCEM R30/6 subline, CCRF-CEM R1, and CCRF-CEM R2 are 2.7, 5.8, 94 and 76 nM, respectively. Cell Viability Assay Cell Line:L1210 and CCRF-CEM cells Concentration:0.1, 0.3, 1, 3, and 10 nM for L1210 cells; 0.3, 1, 3, 10, and 30 for CCRF-CEM cells Incubation Time:48 hours for L1210 cells; 72 hours for CCRF-CEM cells Result:The ED50 values were 0.79 and 2.7 nM for L1210 and CCRF-CEM cells, respectively.
-
In Vivo——
-
SynonymsTNP351
-
PathwayCell Cycle/DNA Damage
-
TargetAntifolate
-
RecptorAntifolate
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number125991-51-7
-
Formula Weight440.46
-
Molecular FormulaC21H24N6O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(CCCC2=CN=C3NC(N)=NC(N)=C32)C=C1)=O
-
Chemical Name(2S)-2-[[4-[3-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)propyl]benzoyl]amino]pentanedioic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Itoh F, et al. Cancer Chemother Pharmacol. 1994;34(4):273-9.
2. Itoh F, et al. Chem Pharm Bull (Tokyo). 1995 Feb;43(2):230-5.
molnova catalog
related products
-
Calcium N5-methyltet...
The calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
-
Pemetrexed disodium
A classical multitargeted antifolate that inhibits multiple folate-requiring enzymes TS/DHFR/GARFT with Ki of 1.3/7.2/65 nM respectively.
-
Mirvetuximab
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1).
Cart
sales@molnova.com